1
|
Selcuk I, Yalcin HR. Correspondence on 'Intrauterine manipulator use during laparoscopic hysterectomy for endometrial cancer: association for pathological factors and oncologic outcomes' by Yoshida et al. Int J Gynecol Cancer 2024:ijgc-2024-005617. [PMID: 38658018 DOI: 10.1136/ijgc-2024-005617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/26/2024] Open
Affiliation(s)
- Ilker Selcuk
- Gynecologic Oncology, Ankara City Hospital, Cankaya, Turkey
| | | |
Collapse
|
2
|
Tokalioglu AA, Oktar O, Sahin M, Ozturk C, Erdogan O, Yildirim HEK, Ucar Y, Kilic F, Ersak B, Yalcin N, Ozmen F, Alci A, Bas S, Gorgulu G, Selcuk I, Ucar G, Kocak O, Cakir C, Kilic C, Comert GK, Ureyen I, Toptas T, Narin MA, Tasci T, Taskin S, Boran N, Ozdal B, Sanci M, Uncu D, Korkmaz V, Tekin OM, Ustun Y, Ortac F, Turan T. Defining the relationship between ovarian adult granulosa cell tumors and synchronous endometrial pathology: Does ovarian tumor size correlate with endometrial cancer? J Obstet Gynaecol Res 2024; 50:655-662. [PMID: 38304973 DOI: 10.1111/jog.15896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2023] [Accepted: 01/17/2024] [Indexed: 02/03/2024]
Abstract
OBJECTIVE The main feature of adult granulosa cell tumors (AGCT) is their capacity to secrete hormones, with nearly all of them capable of synthesizing oestradiol. The primary goal of this study is to identify synchronized endometrial pathologies, particularly endometrial cancer, in AGCT patients who had undergone a hysterectomy. MATERIALS AND METHODS The study cohort comprised retrospectively of 316 AGCT patients from 10 tertiary gynecological oncology centers. AGCT surgery consisted of bilateral salpingo-oophorectomy, hysterectomy, peritoneal cytology, omentectomy, and the excision of any suspicious lesion. The median tumor size value was used to define the relationship between tumor size and endometrial cancer. The relationship between each value and endometrial cancer was evaluated. RESULTS Endometrial intraepithelial neoplasia, or hyperplasia with complex atypia, was detected in 7.3% of patients, and endometrial cancer in 3.1% of patients. Age, menopausal status, tumor size, International Federation of Gynecology and Obstetrics stage, ascites, and CA-125 level were not statistically significant factors to predict endometrial cancer. There was no endometrial cancer under the age of 40, and 97.8% of women diagnosed with endometrial hyperplasia were over the age of 40. During the menopausal period, the endometrial cancer risk was 4.5%. Developing endometrial cancer increased to 12.1% from 3.2% when the size of the tumor was >150 mm in menopausal patients (p = 0.036). CONCLUSION Endometrial hyperplasia, or cancer, occurs in approximately 30% of AGCT patients. Patients diagnosed with AGCT, especially those older than 40 years, should be evaluated for endometrial pathologies. There may be a relationship between tumor size and endometrial cancer, especially in menopausal patients.
Collapse
Affiliation(s)
- Abdurrahman Alp Tokalioglu
- Department of Gynecologic Oncology, Ankara Bilkent City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Okan Oktar
- Department of Gynecologic Oncology, Ankara Etlik City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Mustafa Sahin
- Department of Gynecologic Oncology, Ankara Bilkent City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Cagatayhan Ozturk
- Department of Gynecologic Oncology, Ankara University, Faculty of Medicine, Ankara, Turkey
| | - Ozgur Erdogan
- Department of Gynecologic Oncology, Tepecik Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Izmir, Turkey
| | - Hande Esra Koca Yildirim
- Department of Gynecologic Oncology, Ankara Etlik City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Yesim Ucar
- Department of Gynecologic Oncology, Ankara Bilkent City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Fatih Kilic
- Department of Gynecologic Oncology, Ankara Bilkent City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Burak Ersak
- Department of Gynecologic Oncology, Ankara Etlik City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Necim Yalcin
- Department of Gynecologic Oncology, Antalya Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Antalya, Turkey
| | - Fatma Ozmen
- Department of Gynecologic Oncology, Adana City Hospital, Faculty of Medicine, University of Health Sciences, Adana, Turkey
| | - Aysun Alci
- Department of Gynecologic Oncology, Antalya Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Antalya, Turkey
| | - Sevda Bas
- Department of Gynecologic Oncology, Adana City Hospital, Faculty of Medicine, University of Health Sciences, Adana, Turkey
| | - Goksen Gorgulu
- Department of Gynecologic Oncology, Tepecik Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Izmir, Turkey
| | - Ilker Selcuk
- Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Gokhan Ucar
- Department of Medical Oncology, Ankara Bilkent City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Ozgur Kocak
- Department of Gynecologic Oncology, Hitit University, Faculty of Medicine, Corum, Turkey
| | - Caner Cakir
- Department of Gynecologic Oncology, Ankara Etlik City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Cigdem Kilic
- Department of Gynecologic Oncology, Hitit University, Faculty of Medicine, Corum, Turkey
| | - Gunsu Kimyon Comert
- Department of Gynecologic Oncology, Ankara Bilkent City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Isin Ureyen
- Department of Gynecologic Oncology, Antalya Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Antalya, Turkey
| | - Tayfun Toptas
- Department of Gynecologic Oncology, Antalya Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Antalya, Turkey
| | - Mehmet Ali Narin
- Department of Gynecologic Oncology, Adana City Hospital, Faculty of Medicine, University of Health Sciences, Adana, Turkey
| | - Tolga Tasci
- Department of Gynecologic Oncology, Bahcesehir University, Faculty of Medicine, Istanbul, Turkey
| | - Salih Taskin
- Department of Gynecologic Oncology, Ankara University, Faculty of Medicine, Ankara, Turkey
| | - Nurettin Boran
- Department of Gynecologic Oncology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Bulent Ozdal
- Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Muzaffer Sanci
- Department of Gynecologic Oncology, Tepecik Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Izmir, Turkey
| | - Dogan Uncu
- Department of Medical Oncology, Ankara Bilkent City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Vakkas Korkmaz
- Department of Gynecologic Oncology, Ankara Etlik City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Ozlem Moraloglu Tekin
- Department of Obstetrics and Gynecology, Ankara City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Yaprak Ustun
- Department of Obstetrics and Gynecology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Fırat Ortac
- Department of Gynecologic Oncology, Ankara University, Faculty of Medicine, Ankara, Turkey
| | - Taner Turan
- Department of Gynecologic Oncology, Ankara Bilkent City Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| |
Collapse
|
3
|
Erdogan O, Kilic C, Cakir C, Kilic F, Oktar O, Ersak B, Sahin M, Tokalioglu A, Kocak O, Ozturk C, Gorgulu G, Gokkaya M, Selcuk I, Korkmaz V, Comert GK, Toptas T, Ureyen I, Ucar G, Taskin S, Tasci T, Uncu D, Narin MA, Boran N, Ozdal B, Tekin OM, Ustun Y, Sancı M, Ortac F, Turan T. Is adjuvant chemotherapy necessary for 2014 FIGO stage IC adult granulosa cell tumor?: Multicentric Turkish study. Asia Pac J Clin Oncol 2023. [PMID: 37096294 DOI: 10.1111/ajco.13942] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2022] [Revised: 01/10/2023] [Accepted: 01/11/2023] [Indexed: 04/26/2023]
Abstract
AIM The aim of our study is to examine the clinical, surgical, and pathological factors of stage 1C adult granulosa cell tumor (AGCT) patients and to investigate the effects of adjuvant therapy on recurrence and survival rates in this patient group. METHODS Out of a total of 415 AGCT patients treated by 10 tertiary oncology centers participating in the study, 63 (15.2%) patients with 2014 FIGO stage IC constituted the study group. The FIGO 2014 system was used for staging. Patient group who received adjuvant chemotherapy was compared with patient group who did not receive adjuvant chemotherapy in terms of disease-free survival (DFS), and disease-specific survival. RESULTS The 5-year DFS of the study cohort was 89%, and the 10-year DFS was 85%. Those who received adjuvant chemotherapy and those who did not were similar in terms of clinical, surgical and pathological factors, except for peritoneal cytology. In the univariate analysis, none of the clinical, surgical or pathological factors were significant for DFS. Adjuvant chemotherapy and type of treatment protocol had no impact on DFS. CONCLUSION Adjuvant chemotherapy was not associated with improved DFS and overall survival in stage IC AGCT. Multicentric and randomized controlled studies are needed for early stage AGCT in order to confirm these results and reach accurate conclusions.
Collapse
Affiliation(s)
- Ozgur Erdogan
- Department of Gynecologic Oncology, Tepecik Training and Research Hospital, Izmir, Turkey
| | - Cigdem Kilic
- Department of Gynecologic Oncology, Hitit University, Corum, Turkey
| | - Caner Cakir
- Department of Gynecologic Oncology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Fatih Kilic
- Department of Gynecologic Oncology, Ankara City Hospital, Ankara, Turkey
| | - Okan Oktar
- Department of Gynecologic Oncology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Burak Ersak
- Department of Gynecologic Oncology, Ankara City Hospital, Ankara, Turkey
| | - Mustafa Sahin
- Department of Gynecologic Oncology, Ankara City Hospital, Ankara, Turkey
| | - Alp Tokalioglu
- Department of Gynecologic Oncology, Ankara City Hospital, Ankara, Turkey
| | - Ozgur Kocak
- Department of Gynecologic Oncology, Hitit University, Corum, Turkey
| | | | - Goksen Gorgulu
- Department of Gynecologic Oncology, Tepecik Training and Research Hospital, Izmir, Turkey
| | - Mustafa Gokkaya
- Department of Gynecologic Oncology, Antalya Training and Research Hospital, Antalya, Turkey
| | - Ilker Selcuk
- Department of Gynecologic Oncology, Zekai Tahir Burak Training and Research Hospital, Ankara, Turkey
| | - Vakkas Korkmaz
- Department of Gynecologic Oncology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | | | - Tayfun Toptas
- Department of Gynecologic Oncology, Antalya Training and Research Hospital, Antalya, Turkey
| | - Isin Ureyen
- Department of Gynecologic Oncology, Antalya Training and Research Hospital, Antalya, Turkey
| | - Gokhan Ucar
- Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey
| | - Salih Taskin
- Ankara University, Faculty of Medicine, Ankara, Turkey
| | - Tolga Tasci
- Department of Gynecologic Oncology, Bahcesehir University, Istanbul, Turkey
| | - Dogan Uncu
- Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey
| | - Mehmet Ali Narin
- Department of Gynecologic Oncology, Adana City Hospital, Adana, Turkey
| | - Nurettin Boran
- Department of Gynecologic Oncology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Bulent Ozdal
- Department of Gynecologic Oncology, Zekai Tahir Burak Training and Research Hospital, Ankara, Turkey
| | | | - Yaprak Ustun
- Department of Gynecologic Oncology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Muzaffer Sancı
- Department of Gynecologic Oncology, Tepecik Training and Research Hospital, Izmir, Turkey
| | - Firat Ortac
- Ankara University, Faculty of Medicine, Ankara, Turkey
| | - Taner Turan
- Department of Gynecologic Oncology, Ankara City Hospital, Ankara, Turkey
| |
Collapse
|
4
|
Gómez-Hidalgo NR, Pletnev A, Razumova Z, Bizzarri N, Selcuk I, Theofanakis C, Zalewski K, Nikolova T, Lanner M, Kacperczyk-Bartnik J, El Hajj H, Perez-Benavente A, Nelson G, Gil-Moreno A, Fotopoulou C, Sanchez-Iglesias JL. European Enhanced Recovery After Surgery (ERAS) gynecologic oncology survey: Status of ERAS protocol implementation across Europe. Int J Gynaecol Obstet 2023; 160:306-312. [PMID: 35929452 DOI: 10.1002/ijgo.14386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 07/19/2022] [Accepted: 07/28/2022] [Indexed: 12/31/2022]
Abstract
OBJECTIVE To acquire a comprehensive assessment of the current status of implementation of Enhanced Recovery After Surgery (ERAS) protocols across Europe. METHODS The survey was launched by The European Network of Young Gynecologic Oncologists (ENYGO). A 45-item survey was disseminated online through the European Society of Gynecological Oncology (ESGO) Network database. RESULTS A total of 116 ESGO centers participated in the survey between December 2020 and June 2021. Overall, 80 (70%) centers reported that ERAS was implemented at their institution: 63% reported a length of stay (LOS) for advanced ovarian cancer surgery between 5 and 7 days; 57 (81%) centers reported a LOS between 2 and 4 days in patients who underwent an early-stage gynecologic cancer surgery. The ERAS items with high reported compliance (>75% "normally-always") included deep vein thrombosis prophylaxis (89%), antibiotic prophylaxis (79%), prevention of hypothermia (55%), and early mobilization (55%). The ERAS items that were poorly adhered to (less than 50%) included early removal of urinary catheter (33%), and avoidance of drains (25%). CONCLUSION This survey shows broad implementation of ERAS protocols across Europe; however, a wide variation in adherence to the various ERAS protocol items was reported.
Collapse
Affiliation(s)
- Natalia R Gómez-Hidalgo
- Center of Gynecologic Oncology, Department of Gynecology, Vall d'Hebron Barcelona Hospital Campus, Autonoma University of Barcelona (UAB), Barcelona, Spain
| | - Andrei Pletnev
- Department of Gynecology and Obstetrics, University of Zielona, Góra, Poland
| | - Zoia Razumova
- Department of Women's and Children's Health, Division of Neonatology, Obstetrics and Gynecology, Karolinska Institute, Stockholm, Sweden
| | - Nicolò Bizzarri
- UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario A Gemelli (IRCCS), Rome, Italy
| | - Ilker Selcuk
- Gynaecological Oncology, Maternity Hospital, Ankara City Hospital, Ankara, Turkey
| | | | - Kamil Zalewski
- Gynecological Oncology, Świętokrzyskie Cancer Center, Kielce, Poland
| | - Tanja Nikolova
- Klinikum Mittelbaden, Academic Teaching Hospital of Heidelberg University, Baden-Baden, Germany
| | - Maximilian Lanner
- Department of Obstetrics and Gynecology, Kardinal Schwarzenberg Klinikum, Schwarzach im Pongau, Austria
| | | | - Houssein El Hajj
- Department of Surgical Oncology, Oscar Lambret Cancer Center, Lille, France
| | - Assumpció Perez-Benavente
- Center of Gynecologic Oncology, Department of Gynecology, Vall d'Hebron Barcelona Hospital Campus, Autonoma University of Barcelona (UAB), Barcelona, Spain
| | - Gregg Nelson
- Division of Gynecologic Oncology, Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Antonio Gil-Moreno
- Center of Gynecologic Oncology, Department of Gynecology, Vall d'Hebron Barcelona Hospital Campus, Autonoma University of Barcelona (UAB), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain
| | - Christina Fotopoulou
- West London Gynecological Cancer Centre; Hammersmith Hospital, Imperial College, London, UK
| | - Jose Luis Sanchez-Iglesias
- Center of Gynecologic Oncology, Department of Gynecology, Vall d'Hebron Barcelona Hospital Campus, Autonoma University of Barcelona (UAB), Barcelona, Spain
| |
Collapse
|
5
|
Nikolova T, Bossart M, Kacperczyk-Bartnik J, Razumova Z, Strojna A, Bizzarri N, Pletnev A, Gómez-Hidalgo NR, Theofanakis C, Lanner M, Selcuk I, Shushkevich A, Anca CR, Nikolova N, Concin N, Zalewski K. Gender-related differences in career development among gynecologic oncology surgeons in Europe. European Network of Young Gynecologic Oncologists' Survey based data. Front Oncol 2022; 12:1005130. [PMID: 36601477 PMCID: PMC9807173 DOI: 10.3389/fonc.2022.1005130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Accepted: 11/15/2022] [Indexed: 12/12/2022] Open
Abstract
Introduction Gender-related differences in career development are well known issues in various professions. An international survey on gender-related differences was performed among young gynecologic oncology surgeons in Europe to identify potential gender inequalities in career development. Material and methods A survey on demographics, clinical and academic working environment, family/parenting, career development, salary and leadership was sent to all members of the European Network of Young Gynecologic Oncologists (ENYGO), which is a network within the European Society of Gynecologic Oncology (ESGO). Gynecologic oncology surgeons and obstetricians/gynecologists who actively work in this field in Europe were included in the study. Results Responses were analyzed from 192 gynecologic oncology surgeons of whom 65.1% (125/192) were female (median age 37, IQR: 34 - 42) and 34.9% (67/192) were male (median age 38, IQR: 36 - 41). Male reported to perform a median of 15 and female a median of 10 operations per month (p = .007). Among female, 24.8% had a leadership position vs. 44.8% among male, crude OR = 2.46, 95% CI 1.31-4.62, p<.01. When stratifying for age under 41 and having children, 36.7% of male and 5.6% of female had a leadership position, adjusted OR 10.8, 95% CI 3.28-35.64, p<.001. A significantly higher proportion of female compared to male believed they earned less than their gender counterparts at the same clinical position and with same qualifications (30.4% vs. 2.5%, p<.001). There was not a statistically significant gender difference in the academic qualification PhD degree or professorship (p = .92 and p = .64, respectively). In the previous year, male published more peer-reviewed articles than female (median 3 vs. median 2; p = .017). Conclusion This first comprehensive survey on gender-differences in gynecologic oncology in Europe revealed that there are gender gaps concerning several aspects during the critical time of career development in the young generation of gynecologic oncology surgeons. These gender gaps are particularly reflected by a lower rate of female leadership positions. ENYGO and ESGO are dedicated to work on solution to overcome the identified obstacles and to support closing gender gaps.
Collapse
Affiliation(s)
- Tanja Nikolova
- Klinikum Mittelbaden, Academic Teaching Hospital of Heidelberg University, Baden-Baden, Germany,*Correspondence: Tanja Nikolova,
| | - Michaela Bossart
- Department of Obstetrics and Gynecology, St. Josefskrankenhaus, Freiburg, Germany
| | | | - Zoia Razumova
- Department of Women’s and Children’s Health, Karolinska Institute, Stockholm, Sweden
| | - Alexandra Strojna
- Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany
| | - Nicolò Bizzarri
- Unità Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario a Gemelli, Rome, Italy
| | - Andrei Pletnev
- Department of Obstetrics and Gynecology, University of Zielona Gora, Zielona Gora, Poland
| | - Natalia R. Gómez-Hidalgo
- Gynecological Oncology Department, Vall d’Hebron Hospital, Autonoma University of Barcelona, Barcelona, Spain
| | | | - Maximilian Lanner
- Department of Gynecology, Private Hospital Villach, Villach, Austria
| | - Ilker Selcuk
- Department of Gynecologic Oncology, Ankara City Hospital, Ankara, Turkey
| | - Alexander Shushkevich
- Department of Surgery, Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine
| | - Chelariu-Raicu Anca
- Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximillians-University, Munich, Germany & German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany
| | - Natasha Nikolova
- Center of Perinatal and Reproductive Medicine, University of Perugia, Perugia, Italy
| | - Nicole Concin
- Department of Gynecology and Obstetrics, Innsbruck Medical University, Innsbruck, Austria & Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany,Department Gynecologic Oncology, Holycross Cancer Center, Kielce, Poland
| | - Kamil Zalewski
- Department Gynecologic Oncology, Holycross Cancer Center, Kielce, Poland
| |
Collapse
|
6
|
Strojna AN, Kacperczyk-Bartnik J, Angeles MA, Bizzarri N, van Ramshorst GH, Theofanakis C, Bilir E, Razumova Z, Nikolova T, Selcuk I, Wan YLL, Zalewski K, Lanner M, Pletnev A, Pareja R, Fotopoulou C, Kehoe S, Bąk J, Ramirez PT. ENYGO-IJGC scientific writing and publication course: 2021 meeting summary. Int J Gynecol Cancer 2022; 32:1599-1605. [PMID: 36418053 DOI: 10.1136/ijgc-2022-003868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Affiliation(s)
- Aleksandra Natalia Strojna
- Department of Gynecology and Gynecologic Oncology, Evangelische Kliniken Essen-Mitte, Kliniken Essen-Mitte Evangelische Huyssens-Stiftung/Knappschaft GmbH Klinik fur Gynakologie & Gynakologische Onkologie, Essen, Nordrhein-Westfalen, Germany
| | | | - Martina Aida Angeles
- Department of Surgical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
| | - Nicolò Bizzarri
- UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Policlinico Agostino Gemelli IRCCS, Rome, Italy
| | | | - Charlampos Theofanakis
- Department of Gynaecological Oncology, General Hospital of Athens Alexandra, Athens, Attica, Greece
| | - Esra Bilir
- Department of Gynecologic Oncology, Koc University School of Medicine, Istanbul, Turkey.,Department of Global Health, Koc University Graduate School of Health Sciences, Istanbul, Turkey
| | - Zoia Razumova
- Women's and Children's Health, Karolinska Institute, Stockholm, Sweden
| | - Tanja Nikolova
- Klinikum Mittelbaden, Academic Teaching Hospital of Heidelberg University, Baden-Baden, Germany
| | - Ilker Selcuk
- Gynecologic Oncology, Ankara City Hospital, Cankaya, Turkey
| | - Yee-Loi Louise Wan
- Gynaecological Oncology, The University of Manchester Faculty of Medical and Human Sciences, Manchester, UK
| | - Kamil Zalewski
- Department of Gynecologic Oncology, Holycross Cancer Center, Kielce, Holycross, Poland.,Department of Gynaecology, Royal Marsden Hospital NHS Trust, Department of Gynaecology, Royal Marsden Hospital NHS Trust, London, UK
| | - Maximilian Lanner
- Department of Gynaecology, Private Hospital Villach, Villach, Steiermark, Austria
| | - Andrei Pletnev
- Department of Gynecology and Obstetrics, University of Zielona Góra, Zielona Góra, Poland
| | - Rene Pareja
- Gynecology, Gynecologic Oncology, Clinica ASTORGA, Medellin, and Instituto Nacional de Cancerología, Bogotá, Colombia, Medellin, Colombia
| | | | - Sean Kehoe
- University of Birmingham College of Medical and Dental Sciences, Birmingham, Oxfordshire, UK
| | - Janina Bąk
- https://janinadaily.com, Wrocław, Poland
| | - Pedro T Ramirez
- Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Houston, Texas, USA
| |
Collapse
|
7
|
Razumova Z, Bizzarri N, Pletnev A, Theofanakis C, Selcuk I, van der Steen-Banasik E, Gonzalez Martin A, Persson J. 22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report. Int J Gynecol Cancer 2022; 32:1363-1369. [PMID: 36198434 DOI: 10.1136/ijgc-2022-003593] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
This is a report from the 22nd Meeting of the European Society of Gynaecological Oncology, held October 23-25, 2021. The 3-day event offered an educational experience covering the major scientific and clinical advances in gynecological oncology. The Congress program included different session formats, including guidelines updates and state-of-the-art lectures. This article provides an overview of the main Congress activities as well as of the most important studies that were presented at the event for the first time.
Collapse
Affiliation(s)
- Zoia Razumova
- Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden
| | - Nicolò Bizzarri
- UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Policlinico Agostino Gemelli IRCCS, Rome, Italy
| | - Andrei Pletnev
- Department of Gynecology and Obstetrics, Faculty of Medicine and Health Sciences, University of Zielona Góra, Zielona Gora, Poland
| | - Charlampos Theofanakis
- Department of Gynaecological Oncology, General Hospital of Athens Alexandra, Athens, Greece
| | - Ilker Selcuk
- Gynecologic Oncology, Ankara City Hospital, Ankara, Turkey
| | | | - Antonio Gonzalez Martin
- Department of Medical Oncology, Clinica Universidad de Navarra, Madrid, Spain.,Centre for Applied Medical Research (CIMA), Pamplona, Spain
| | - Jan Persson
- Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, Skåne University Hospital, Lund, Sweden.,Department of Clinical Sciences, Lund University Faculty of Medicine, Lund, Sweden
| |
Collapse
|
8
|
Selcuk I. Correspondence on 'Simplified anatomical nomenclature of lateral female pelvic spaces' by Querleu et al. Int J Gynecol Cancer 2022; 32:1495. [DOI: 10.1136/ijgc-2022-003929] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
9
|
Kacperczyk-Bartnik J, Nowosielski K, Razumova Z, Bizzarri N, Pletnev A, Lindquist D, Lanner M, Nikolova T, Theofanakis C, Strojna AN, Bartnik P, Gómez-Hidalgo NR, Vlachos DE, Selcuk I, Zalewski K. Clinician attitude towards sexual counseling in women with gynecologic malignancies: European Network of Young Gynaecological Oncologists (ENYGO) survey. Int J Gynecol Cancer 2022; 32:ijgc-2021-003309. [PMID: 35568382 DOI: 10.1136/ijgc-2021-003309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
OBJECTIVE Both the location of primary disease and treatment side effects may have an impact on sexual function in oncogynecological patients. The aim of this study was to examine the prevalence, strategies, difficulties, and ideas for improvement in sexual counseling among specialists managing patients with gynecologic malignancies. METHODS This was a cross-sectional survey study performed among healthcare professionals treating patients with gynecologic malignancies. A self-prepared questionnaire included 61 questions concerning general demographic information and different aspects of sexual counseling in the gynecologic oncology practice. Analysis included attitudes, behaviors, management strategies, difficulties, and ideas for possible systemic improvements. Statistical analysis involved descriptive statistics, two-sided chi-square test, and Fisher's exact test. RESULTS A total of 150 respondents from 46 countries answered the survey. The majority of survey participants stated that sexual counseling of oncological patients is very important (n=73, 49%) or important (n=46, 31%). One hundred and two (68%) respondents agreed that sexual counseling of gynecologic oncology patients should be routinely provided by the specialist managing the primary disease. However, collecting information concerning sexual function is performed often or always by only 21% of respondents and 19% discuss the topic rarely or never. The most frequently indicated barriers leading to difficulties in sexual counseling include lack of time (74%), lack of specialist knowledge (55%), and patient embarrassment (48%). One hundred and seven (71%) respondents expressed interest in participating in sexual counseling workshops organized by the European Society of Gynaecological Oncology (ESGO)/European Network of Young Gynaecological Oncologists (ENYGO), 74 (49%) would like to access webinars on the topic, and 120 (80%) would be interested in materials in the ESGO online educational resources. CONCLUSION One of the proposed solutions to insufficient access to sexual care for women with gynecologic malignancies is providing access to specialist educational programs for both patients and healthcare specialists.
Collapse
Affiliation(s)
| | - Krzysztof Nowosielski
- Department of Gynecology, Obstetrics and Gynecological Oncology, University Clinical Center, Medical University of Silesia, Katowice, Poland
| | - Zoia Razumova
- Women's and Children's Health, Karolinska Institute, Stockholm, Sweden
| | - Nicolò Bizzarri
- UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | - Andrei Pletnev
- Department of Gynecology and Obstetrics, University of Zielona Góra, Zielona Góra, Poland
| | - David Lindquist
- Department of Clinical Sciences, Umeå University, Umeå, Sweden
| | - Maximilian Lanner
- Department of Obstetrics and Gynaecology, Kardinal Schwarzenberg'sches Krankenhaus, Schwarzach, Steiermark, Austria
| | - Tanja Nikolova
- Department of Gynecologic Oncology, Klinikum Mittelbaden, Academic Teaching Hospital of Heidelberg University, Baden-Baden, Germany
| | - Charlampos Theofanakis
- Department of Gynaecological Oncology, General Hospital of Athens Alexandra, Athens, Greece
| | | | - Paweł Bartnik
- II Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland
| | | | - Dimitrios-Efthymios Vlachos
- First Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Athens, Greece
| | - Ilker Selcuk
- Department of Gynecologic Oncology, Zekai Tahir Burak Kadin Sagligi EAH, Ankara, Turkey
| | - Kamil Zalewski
- Department of Gynecologic Oncology, Holycross Cancer Center, Kielce, Poland
- Department of Gynaecology, Royal Marsden Hospital NHS Trust, London, UK
| |
Collapse
|
10
|
Selcuk I, Yalcin HR. Superior and inferior hypogastric plexus. Int J Gynecol Cancer 2022; 32:576-577. [DOI: 10.1136/ijgc-2022-003438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
11
|
Akgor U, Ayhan A, Shushkevich A, Ozdal B, Angelou K, Akbayır O, Kaidarova D, Ulrikh E, Stepanyan A, Ortac F, Aliyev S, Ozgul N, Taranenka S, Haberal A, Salman C, Seyhan A, Selcuk I, Haidopoulos D, Akıllı H, Bolatbekova R, Alaverdyan A, Taskin S, Murshudova S, Batur M, Berlev I, Gultekin M. OPEC study: An international multicenter study of ovarian preservation in endometrial cancers. Int J Gynaecol Obstet 2022; 159:550-556. [PMID: 35323994 DOI: 10.1002/ijgo.14190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2021] [Revised: 02/17/2022] [Accepted: 03/16/2022] [Indexed: 11/07/2022]
Abstract
OBJECTIVE To evaluate the feasibility and oncological safety of ovarian preservation in early stage endometrial adenocarcinoma (EC) patients aged 40 and below. METHODS A total of 11 institutions from eight countries participated in the study. 169 of 5898 patients aged ≤40 years were eligible for the study. Patients with EC treated between March 2007 and January 2019 were retrospectively assessed. RESULTS The median duration of follow-up after EC diagnosis was 59 months (4-187). Among 169 participants, ovarian preservation surgery (OPS) was performed in 54 (31.9%), and BSO was performed in 115 (68.1%) patients. Although patients younger than 30 years of age were more likely to have OPS than patients aged 30 to 40 years (20.4% vs. 9.6%, P = 0.021), there was no significant difference by the mean age. There were no other relevant baseline differences between OPS and BSO groups. The Kaplan-Meier analysis revealed no difference in either the overall survival (P = 0.955) or recurrence-free survival (P = 0.068) among patients who underwent OPS, and BSO. CONCLUSION OPS appears to be safe without having any adverse impact on survival in women aged ≤40 years with FIGO Stage I EC.
Collapse
Affiliation(s)
- Utku Akgor
- Department of Gynecologic Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
| | - Ali Ayhan
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Ankara, Turkey
| | - Alexander Shushkevich
- Department of Gynecologic Oncology, N.N. Alexandrov Cancer Center of Belarus, Minsk, Belarus
| | - Bulent Ozdal
- Department of Gynecologic Oncology, Ankara, Turkey
| | - Kyveli Angelou
- Gynecologic Oncology Unit, 1st Department of Obstetrics and Gynecology, Alexandra Hospital, University of Athens, Athens, Greece
| | - Ozgur Akbayır
- Department of Gynecologic Oncology, Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Turkey
| | - Dilyara Kaidarova
- Oncogynecology Center, Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
| | - Elena Ulrikh
- North-Western State Medical University, N.N. Petrov Research Institute of Oncology, Saint-Petersburg, Russian Federation
| | - Artem Stepanyan
- Department of Gynecologic Oncology, NAIRI Medical Center, Yerevan, Armenia
| | - Fırat Ortac
- Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, School of Medicine, Ankara University, Ankara, Turkey
| | | | - Nejat Ozgul
- Department of Gynecologic Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
| | - Siarhei Taranenka
- Department of Gynecologic Oncology, N.N. Alexandrov Cancer Center of Belarus, Minsk, Belarus
| | - Ali Haberal
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Ankara, Turkey
| | - Coskun Salman
- Department of Gynecologic Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
| | - Alper Seyhan
- Department of Gynecologic Oncology, Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Turkey
| | - Ilker Selcuk
- Department of Gynecologic Oncology, Ankara, Turkey
| | - Dimitrios Haidopoulos
- Gynecologic Oncology Unit, 1st Department of Obstetrics and Gynecology, Alexandra Hospital, University of Athens, Athens, Greece
| | - Huseyin Akıllı
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Ankara, Turkey
| | - Raikhan Bolatbekova
- Oncogynecology Center, Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
| | - Areg Alaverdyan
- Department of Gynecologic Oncology, NAIRI Medical Center, Yerevan, Armenia
| | - Salih Taskin
- Division of Gynaecologic Oncology, Department of Obstetrics and Gynaecology, School of Medicine, Ankara University, Ankara, Turkey
| | | | - Meltem Batur
- Department of Gynecologic Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
| | - Igor Berlev
- North-Western State Medical University, N.N. Petrov Research Institute of Oncology, Saint-Petersburg, Russian Federation
| | - Murat Gultekin
- Department of Gynecologic Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
| |
Collapse
|
12
|
Bizzarri N, Pletnev A, Razumova Z, Zalewski K, Theofanakis C, Selcuk I, Nikolova T, Lanner M, Gómez-Hidalgo NR, Kacperczyk-Bartnik J, Querleu D, Cibula D, Verheijen RHM, Fagotti A. Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO). Int J Gynecol Cancer 2022; 32:494-501. [PMID: 34992130 DOI: 10.1136/ijgc-2021-002812] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
BACKGROUND The European Society of Gynaecological Oncology (ESGO) and partners are committed to improving the training for gynecologic oncology fellows. The aim of this survey was to assess the type and level of training in cervical cancer surgery and to investigate whether the Laparoscopic Approach to Cervical Cancer (LACC) trial results impacted training in radical surgery for gynecologic oncology fellows. METHODS In June 2020, a 47-question electronic survey was shared with European Network of Young Gynaecologic Oncologists (ENYGO) members. Specialist fellows in obstetrics and gynecology, and gynecologic oncology, from high- and low-volume centers, who started training between January 1, 2017 and January 1, 2020 or started before January 1, 2017 but finished their training at least 6 months after the LACC trial publication (October 2018), were included. RESULTS 81 of 125 (64.8%) respondents were included. The median time from the start of the fellowship to completion of the survey was 28 months (range 6-48). 56 (69.1%) respondents were still fellows-in-training. 6 of 56 (10.7%) and 14 of 25 (56.0%) respondents who were still in training and completed the fellowship, respectively, performed ≥10 radical hysterectomies during their training. Fellows trained in an ESGO accredited center had a higher chance to perform sentinel lymph node biopsy (60.4% vs 30.3%; p=0.027). There was no difference in the mean number of radical hysterectomies performed by fellows during fellowship before and after the LACC trial publication (8±12.0 vs 7±8.4, respectively; p=0.46). A significant reduction in number of minimally invasive radical hysterectomies was noted when comparing the period before and after the LACC trial (38.5% vs 13.8%, respectively; p<0.001). CONCLUSION Exposure to radical surgery for cervical cancer among gynecologic oncology fellows is low. Centralization of cervical cancer cases to high-volume centers may provide an increase in fellows' exposure to radical procedures. The LACC trial publication was associated with a decrease in minimally invasive radical hysterectomies performed by fellows.
Collapse
Affiliation(s)
- Nicolò Bizzarri
- UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Policlinico Agostino Gemelli IRCCS, Rome, Italy
| | - Andrei Pletnev
- Department of Obstetrics and Gynecology, University of Zielona Góra Faculty of Humanities, Zielona Gora, Poland
| | - Zoia Razumova
- Women's and Children's Health, Karolinska Institute, Stockholm, Sweden
| | - Kamil Zalewski
- Gynecologic Oncology, Holycross Cancer Center, Kielce, Holycross, Poland
| | - Charalampos Theofanakis
- Department of Gynaecological Oncology, General Hospital of Athens Alexandra, Athens, Attica, Greece
| | - Ilker Selcuk
- Gynecologic Oncology, Maternity Hospital, Ankara City Hospital, Ankara, Turkey
| | - Tanja Nikolova
- Klinikum Mittelbaden, Academic Teaching Hospital of Heidelberg University, Baden-Baden, Germany
| | - Maximilian Lanner
- Kardinal Schwarzenberg'sches Krankenhaus, Schwarzach im Pongau, Steiermark, Austria
| | - Natalia R Gómez-Hidalgo
- Unit of Gynecologic Oncology, Department of Obstetrics and Gynecology, Vall d'Hebron Hospital, Barcelona, Spain
| | | | - Denis Querleu
- UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Policlinico Agostino Gemelli IRCCS, Rome, Italy.,Department of Obstetrics and Gynecology, University Hospital of Strasbourg, Strasbourg, France
| | - David Cibula
- Department of Obstetrics and Gynecology, Charles University and General University Hospital in Prague, Prague, Czech Republic
| | - René H M Verheijen
- Cancer Center, Department Gynaecological Oncology, UMC Utrecht, Utrecht, The Netherlands.,Nérac, Lot-et-Garonne, France
| | - Anna Fagotti
- UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Policlinico Agostino Gemelli IRCCS, Rome, Italy.,Università Cattolica del Sacro Cuore, Rome, Italy
| |
Collapse
|
13
|
Gaba F, Blyuss O, Rodriguez I, Dilley J, Wan YLL, Saiz A, Razumova Z, Zalewski K, Nikolova T, Selcuk I, Bizzarri N, Theofanakis C, Lanner M, Pletnev A, Gurumurthy M, Manchanda R. Impact of SARS-CoV-2 on training and mental well-being of surgical gynecological oncology trainees. Int J Gynecol Cancer 2021; 31:1268-1277. [PMID: 34326158 DOI: 10.1136/ijgc-2021-002803] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2021] [Accepted: 07/15/2021] [Indexed: 12/15/2022] Open
Abstract
INTRODUCTION The SARS-CoV-2 global pandemic has caused a crisis disrupting health systems worldwide. While efforts are being made to determine the extent of the disruption, the impact on gynecological oncology trainees/training has not been explored. We conducted an international survey of the impact of SARS-CoV-2 on clinical practice, medical education, and mental well-being of surgical gynecological oncology trainees. METHODS In our cross-sectional study, a customized web-based survey was circulated to surgical gynecological oncology trainees from national/international organizations from May to November 2020. Validated questionnaires assessed mental well-being. The Wilcoxon rank-sum test and Fisher's exact test were used to analyse differences in means and proportions. Multiple linear regression was used to evaluate the effect of variables on psychological/mental well-being outcomes. Outcomes included clinical practice, medical education, anxiety and depression, distress, and mental well-being. RESULTS A total of 127 trainees from 34 countries responded. Of these, 52% (66/127) were from countries with national training programs (UK/USA/Netherlands/Canada/Australia) and 48% (61/127) from countries with no national training programs. Altogether, 28% (35/125) had suspected/confirmed COVID-19, 28% (35/125) experienced a fall in household income, 20% (18/90) were self-isolated from households, 45% (57/126) had to re-use personal protective equipment, and 22% (28/126) purchased their own. In total, 32.3% (41/127) of trainees (16.6% (11/66) from countries with a national training program vs 49.1% (30/61) from countries with no national training program, p=0.02) perceived they would require additional time to complete their training fellowship. The additional training time anticipated did not differ between trainees from countries with or without national training programs (p=0.11) or trainees at the beginning or end of their fellowship (p=0.12). Surgical exposure was reduced for 50% of trainees. Departmental teaching continued throughout the pandemic for 69% (87/126) of trainees, although at reduced frequency for 16.1% (14/87), and virtually for 88.5% (77/87). Trainees reporting adequate pastoral support (defined as allocation of a dedicated mentor/access to occupational health support services) had better mental well-being with lower levels of anxiety/depression (p=0.02) and distress (p<0.001). Trainees from countries with a national training program experienced higher levels of distress (p=0.01). Mean (SD) pre-pandemic mental well-being scores were significantly higher than post-pandemic scores (8.3 (1.6) vs 7 (1.8); p<0.01). CONCLUSION SARS-CoV-2 has negatively impacted the surgical training, household income, and psychological/mental well-being of surgical gynecological oncology trainees. The overall clinical impact was worse for trainees in countries with no national training program than for those in countries with a national training program, although national training program trainees reported greater distress. COVID-19 sickness increased anxiety/depression. The recovery phase must focus on improving mental well-being and addressing lost training opportunities.
Collapse
Affiliation(s)
- Faiza Gaba
- Department of Gynaecological Oncology, NHS Grampian, Aberdeen, UK .,Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
| | - Oleg Blyuss
- Department of Physics, Astronomy and Mathematics, University of Hertfordshire, Hatfield, UK.,Department of Pediatrics and Pediatric Infectious Diseases, Institute of Child's Health, Sechenov University, Moskva, Russian Federation
| | - Isabel Rodriguez
- Department of Gynecologic Oncology, University of Washington, Seattle, Washington, USA
| | - James Dilley
- Department of Gynaecological Oncology, Barts and The London NHS Trust, London, UK
| | - Yee-Loi Louise Wan
- Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
| | - Allison Saiz
- Department of Gynecologic Oncology, Northwestern University in Chicago, Chicago, Illinois, USA
| | - Zoia Razumova
- Women's and Children's Health, Karolinska Institute, Stockholm, Sweden
| | - Kamil Zalewski
- Department of Gynecologic Oncology, Świętokrzyskie Cancer Centre, Kielce, Poland
| | - Tanja Nikolova
- Department of Gynecologic Oncology, Academic Teaching Hospital of Heidelberg University, Baden-Baden, Germany
| | - Ilker Selcuk
- Department of Gynecologic Oncology, Ankara City Hospital, Ankara, Turkey
| | - Nicolò Bizzarri
- UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Policlinico Agostino Gemelli IRCCS, Rome, Italy
| | - Charalampos Theofanakis
- Department of Gynaecological Oncology, General Hospital of Athens Alexandra, Athens, Attica, Greece
| | - Maximilian Lanner
- Department of Obstetrics/Gynaecology, Kardinal Schwarzenberg'sches Krankenhaus, Schwarzach, Steiermark, Austria
| | - Andrei Pletnev
- Department of Gynecology and Obstetrics, University of Zielona Góra, Zielona Góra, Poland
| | | | - Ranjit Manchanda
- Department of Gynaecological Oncology, Barts and The London NHS Trust, London, UK .,Wolfson Institute of Preventive Medicine, Barts CRUK Cancer Centre, Queen Mary University of London, London, UK
| |
Collapse
|
14
|
Lanner M, Nikolova T, Gutic B, Nikolova N, Pletnev A, Selcuk I, Vlachos DE, Razumova Z, Bizzarri N, Theofanakis C, Lepka P, Kahramanoglu I, Han S, Nasser S, Molnar S, Hudry D, Montero-Macías R, de Lange N, Macuks R, Hasanov MF, Karimbayli R, Gagua I, Andrade C, Pardal C, Dotlic J, Alvarez RM, Hruda M, Fruhauf F, Ekdahl L, Antonsen SL, Sukhin V, Eriksson AGZ, Gliozheni E, Delic R, Satanova A, Kovacevic N, Gristsenko L, Babloyan S, Zalewski K, Bharathan R. Subspecialty training in Europe: a report by the European Network of Young Gynaecological Oncologists. Int J Gynecol Cancer 2020; 31:575-584. [PMID: 33361458 DOI: 10.1136/ijgc-2020-002176] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2020] [Revised: 12/14/2020] [Accepted: 12/16/2020] [Indexed: 11/03/2022] Open
Abstract
BACKGROUND ESGO (European Society of Gynaecological Oncology) and partners are continually improving the developmental opportunities for gynaecological oncology fellows. The objectives of this survey were to evaluate the progress in the infrastructure of the training systems in Europe over the past decade. We also evaluated training and assessment techniques, the perceived relevance of ENYGO (European Network of Young Gynaecological Oncologists) initiatives, and unmet needs of trainees. METHODOLOGY National representatives of ENYGO from 39 countries were contacted with an electronic survey. A graduation in well/moderately/loosely-structured training systems was performed. Descriptive statistical analysis and frequency tables, as well as two-sided Fisher's exact test, were used. RESULTS National representatives from 33 countries answered our survey questionnaire, yielding a response rate of 85%. A national fellowship is offered in 22 countries (66.7%). A logbook to document progress during training is mandatory in 24 (72.7%) countries. A logbook of experience is only utilized in a minority of nations (18%) for assessment purposes. In 42.4% of countries, objective assessments are recognized. Trainees in most countries (22 (66.7%)) requested additional training in advanced laparoscopic surgery. 13 (39.4%) countries have a loosely-structured training system, 11 (33.3%) a moderately-structured training system, and 9 (27.3%) a well-structured training system. CONCLUSION Since the last publication in 2011, ENYGO was able to implement new activities, workshops, and online education to support training of gynaecological oncology fellows, which were all rated by the respondents as highly useful. This survey also reveals the limitations in establishing more accredited centers, centralized cancer care, and the lack of laparoscopic training.
Collapse
Affiliation(s)
- Maximilian Lanner
- Department of Obstetrics and Gynaecology, Kardinal Schwarzenberg Klinikum, Schwarzach im Pongau, Austria
| | - Tanja Nikolova
- Klinikum Mittelbaden, Academic Teaching Hospital of Heidelberg University, Baden-Baden, Germany
| | - Bojana Gutic
- Gynaecology Department, Vojvodina Institute of Oncology, Sremska Kamenica, Serbia
| | - Natasha Nikolova
- Department of Obstetrics and Gynaecology and Centre for Perinatal and Reproductive Medicine, University of Perugia, Perugia, Italy
| | - Andrei Pletnev
- Department of Gynaecological Oncology, N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus
| | - Ilker Selcuk
- Gynaecological Oncology, Maternity Hospital, Ankara City Hospital, Ankara, Turkey
| | - Dimitrios-Efthymios Vlachos
- First Department of Obstetrics and Gynaecology, National and Kapodistrian University of Athens, Athens, Greece
| | - Zoia Razumova
- Department of Women's and Children's Health, Division of Neonatology, Obstetrics and Gynaecology, Karolinska Institute, Stockholm, Sweden
| | - Nicolò Bizzarri
- UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy
| | - Charlampos Theofanakis
- Department of Gynaecological Oncology, General Hospital of Athens Alexandra, Athens, Attica, Greece
| | - Piotr Lepka
- Department of Oncology, Gynaecological Oncology Clinic, Wroclaw Medical University and 2nd Lower Silesian Oncology Centre, Wroclaw, Poland
| | - Ilker Kahramanoglu
- Department of Obstetrics and Gynaecology, Division of Gynaecological Oncology, Istanbul University Cerrrahpasa Medical Faculty, Istanbul, Turkey
| | - Sileny Han
- Gynaecological Oncology, KU Leuven University Hospitals Leuven, Leuven, Belgium
| | - Sara Nasser
- Department of Gynaecological Oncology, Gynaecology Clinic with Oncologic Surgery Centre, Charité Comprehensive Cancer Centre, Campus Virchow Klinikum, Berlin, Germany
| | - Szabolcs Molnar
- Department of Obstetrics and Gynaecology, University of Debrecen Faculty of Medicine, Debrecen, Hungary
| | - Delphine Hudry
- Department of Gynaecological Oncology, Centre Oscar Lambret, Lille, France
| | - Rosa Montero-Macías
- Gynaecologic and Breast Oncologic Surgery Department, European Hospital Group Georges-Pompidou, Paris, France
| | - Natascha de Lange
- Department of Gynaecological Oncology, Universitair Medisch Centrum Groningen, Groningen, Netherlands
| | - Ronalds Macuks
- Department of Obstetrics and Gynaecology, Riga Stradins University, Riga, Latvia
| | - Mir Fuad Hasanov
- Department of Obstetrics and Gynaecology, Medical Center-University of Freiburg, Freiburg, Baden-Württemberg, Germany
| | - Ramina Karimbayli
- Department of Oncogynaecology, The National Centre of Oncology, Baku, Azerbaijan
| | - Irina Gagua
- Department of Gynaecology, Research Institute of Clinical Medicine, Todua Clinic, Tbilisi, Georgia
| | - Claudia Andrade
- Department of Gynaecology, Centro Hospitalar e Universitário de Coimbra EPE, Coimbra, Portugal
| | - Catarina Pardal
- Department of Obstetrics and Gynaecology, Hospital de Braga, Braga, Portugal
| | - Jelena Dotlic
- Clinic of Obstetrics and Gynaecology, Clinical Centre of Serbia, University of Belgrade, Beograd, Serbia
| | - Rosa Maria Alvarez
- Department of Gynaecological Oncology and Breast Cancer, Santa Cristina University Hospital, Madrid, Spain
| | - Martin Hruda
- Department of Obstetrics and Gynaecology, 3rd Medical Faculty, Charles University and Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic
| | - Filip Fruhauf
- Department of Obstetrics and Gynaecology, General University Hospital, Charles University, Prague, Czech Republic
| | - Linnea Ekdahl
- Department of Obstetrics and Gynaecology, Division of Gynaecologic Oncology, Skåne University Hospital Lund, Lund, Sweden
| | - Sofie Leisby Antonsen
- Gynaecological Department, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
| | - Vladyslav Sukhin
- Department for Gynaecological Oncology, Grigoriev Institute for medical Radiology and Oncology NAMS, Kharkov, Ukraine
| | - Ane Gerda Zahl Eriksson
- Department of Gynaecological Oncology, Division of Cancer Medicine, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
| | - Elko Gliozheni
- Department of Obstetrics and Gynaecology, Maternity Koco Gliozheni Hospital, Tirana, Albania
| | - Ratko Delic
- Department of Obstetrics and Gynaecology, General Hospital Celje, Celje, Slovenia
| | - Alima Satanova
- Department of Gynaecological Oncology, Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
| | - Nina Kovacevic
- Department of Gynaecological Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
| | - Liidia Gristsenko
- Department of Obstetrics and Gynaecology, The North Estonian Medical Centre, Tallinn, Estonia
| | - Suzanna Babloyan
- Department of Obstetrics and Gynaecology, Yerevan State Medical University, Yerevan, Armenia
| | - Kamil Zalewski
- Gynaecological Oncology, Świętokrzyskie Cancer Centre, Kielce, Poland
| | - Rasiah Bharathan
- Department of Gynaecological Oncology, Maidstone Hospital, Maidstone, Kent, UK
| |
Collapse
|
15
|
Bizzarri N, Razumova Z, Selcuk I, Taumberger N, Nikolova T, Fotopoulou C, Van der Steen-Banasik E, Ferrero A, Zalewski K. Report from the 21st meeting of the European Society of Gynaecological Oncology (ESGO 2019). Int J Gynecol Cancer 2020; 30:441-447. [DOI: 10.1136/ijgc-2020-001226] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2020] [Accepted: 01/14/2020] [Indexed: 12/12/2022] Open
Abstract
This is a report from the 21st Meeting of the European Society of Gynaecological Oncology (ESGO 2019) held in Athens, Greece, November 2–5, 2019. The conference offered state of the art educational sessions, and oral and poster abstract presentations. The general sessions throughout the meeting focused not only on prevention, screening, diagnosis, treatment, and translational research but also on emerging trends. Current innovations in gynecological cancers were also discussed. The new rare tumor guidelines project, a joint initiative with the ESGO-Gynecologic Cancer InterGroup, was officially presented for the first time. Moreover, other developments achieved with other societies, such as the European Society for Medical Oncology for ovarian cancer, the European Federation for Colposcopy for cervical cancer prevention and screening, and the European Society for Pediatric Oncology for gynecologic cancers in adolescents, were presented. Here we highlight the key results of the latest gynecological cancer trials that were presented for the first time at ESGO 2019 and added great value to this prestigious scientific congress.
Collapse
|
16
|
Selcuk I, Meydanli MM, Yalcin I, Gungorduk K, Akgol S, Çelik H, Ayhan A. Comparison of survival outcomes in optimally and maximally cytoreduced stage IIIC ovarian high-grade serous carcinoma: Women with only peritoneal tumor burden versus women with both peritoneal and lymphogenous dissemination. J Obstet Gynaecol Res 2019; 45:2074-2081. [PMID: 31373110 DOI: 10.1111/jog.14075] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2019] [Accepted: 07/15/2019] [Indexed: 11/28/2022]
Abstract
AIM The aim of this study was to analyze the survival outcomes of stage IIIC ovarian high-grade serous carcinoma (HGSC) patients with both peritoneal and lymphatic dissemination (IP+/RP+) who had undergone maximal or optimal cytoreduction followed by intravenous carboplatin/paclitaxel chemotherapy compared to those women with stage IIIC ovarian HGSC with only peritoneal involvement (IP+/RP-) who were treated similarly. METHODS We performed a retrospective, multicenter study with the participation of five gynecological cancer centers. First, the stage IIIC ovarian HGSC patients were classified into optimally or maximally debulked cohorts. Then, in each cohort, the patients were divided into two groups; the IP+/RP- group included those women with transcoelomic spreading outside the pelvis with no nodal disease, and the IP+/RP+ group included those patients with transcoelomic dissemination outside the pelvis in addition to a positive nodal status. The survival outcomes were compared between the two groups in each cohort. RESULTS A total of 405 ovarian HGSC patients were analyzed. In the optimally debulked cohort (n = 257), the progression-free survival (PFS) and overall survival (OS) medians for the IP+/RP- group (n = 69) were 24 and 57 months, respectively, compared to 21 and 58 months, respectively, for the IP+/RP+ group (n = 188) (P = 0.78 and P = 0.40, respectively). In the maximally debulked cohort (n = 148), the PFS and OS medians for the IP+/RP- group (n = 55) were 35 and 63 months, respectively, compared to 25 and 51 months, respectively, for the IP+/RP+ group (n = 93) (P = 0.49 and P = 0.31, respectively). CONCLUSION Our findings indicated no survival differences between the IP+/RP- and the IP+/RP+ groups.
Collapse
Affiliation(s)
- Ilker Selcuk
- Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Mehmet M Meydanli
- Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Ibrahim Yalcin
- Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey
| | - Kemal Gungorduk
- Department of Gynecologic Oncology, Tepecik Education and Research Hospital, Faculty of Medicine, University of Health Sciences, Izmir, Turkey
| | - Sedat Akgol
- Department of Gynecologic Oncology, Kanuni Sultan Suleyman Teaching and Research Hospital, Faculty of Medicine, University of Health Sciences, Istanbul, Turkey
| | - Husnu Çelik
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Ankara, Turkey
| | - Ali Ayhan
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Ankara, Turkey
| |
Collapse
|
17
|
Gungorduk K, Ozdemir A, Selcuk I, Telli E, Şahin Ö, Toptaş T, Akman L, Güzel AB, Taşkın S, Öge T, Güngördük Ö, Gokçü M, Gungor T, Yaşar L, Terek MC, Ozan H, Ozsaran A, Sancı M, Vardar MA, Meydanlı MM, Yalçın ÖT, Ortac F, Özalp S. Comparison Of Early-Stage High-Grade Serous Primary Fallopian Tube Cancers and Epithelial Ovarian Cancers: A Multicenter Study. Oncol Res Treat 2017; 40:203-206. [PMID: 28376498 DOI: 10.1159/000458440] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2016] [Accepted: 01/30/2017] [Indexed: 11/19/2022]
Abstract
INTRODUCTION We compared the disease free-survival (DFS) and overall survival (OS) rates of patients with high-grade serous primary fallopian tube cancer (HG-sPFTC) and high-grade serous epithelial ovarian cancer (HG-sEOC). METHODS 22 early-stage cancer patients (International Federation of Gynecology and Obstetrics (FIGO) stages I-II) with HG-sPFTC were retrospectively evaluated. In addition, 44 control patients diagnosed with HG-sEOC were matched to these patients with respect to tumor stage at diagnosis. All patients underwent complete surgical staging, followed by adjuvant chemotherapy. Kaplan-Meier curves were used to generate survival data. RESULTS The mean age of HG-sPFTC patients was 59.4 ± 6.2 years, and that of HG-sEOC patients 55.2 ± 11.0 years (p = 0.002). All patients underwent 6 cycles of platinum-based adjuvant chemotherapy. All operations were optimal. The 5-year DFSs were 77.3% for HG-sPFTC patients and 75% for HG-sEOC patients (p = 1.00).The 5-year OS rates were 81.8% in women with HG-sPFTC and 77.3% in those with HG-sEOC (p = 0.75). CONCLUSION The DFS and OS rates of patients with early-stage (FIGO stages I and II) HG-sPFTC and HG-sEOC were similar. The surgical and adjuvant therapy management of these malignancies should be similar.
Collapse
Affiliation(s)
- Kemal Gungorduk
- Department of Gynecologic Oncology, Tepecik Education and Research Hospital, Izmir, Turkey
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Boyraz G, Selcuk I, Sokmensuer LK, Bozdag G, Menkveld R, Gunalp S. Evaluation of the relation between preapoptotic sperm rate in ejaculate and intrauterine insemination success rate in patients with unexplained infertility. J OBSTET GYNAECOL 2016; 36:980-983. [PMID: 27615728 DOI: 10.1080/01443615.2016.1188269] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
The parameters measured in the standard semen analysis may be insufficient for exact differentiation between fertile and infertile men. Therefore, we assume that the high rate of apoptotic sperm in ejaculate may play a role on the aetiology of unexplained infertility. Couples with unexplained infertility treated by ovulation induction and intrauterine insemination were consecutively enrolled (n = 94). To determine the proapoptotic sperm rate, the ejaculate from patients was stained with annexin V. Thirteen of the 94 couples (13.8%) conceived after intrauterine insemination. The annexin V-positive sperm rate was found to be 20.0% in the whole group. In women failing to conceive, the annexin V-positive sperm rate was 20.8% compared to 15.7% in patients who achieved pregnancy. Although there is a trend towards higher preapoptotic sperm rate in couples failing to get pregnant with insemination, the difference did not reach statistical significance.
Collapse
Affiliation(s)
- Gokhan Boyraz
- a Department of Obstetrics and Gynaecology, Faculty of Medicine , Hacettepe University , Ankara , Turkey
| | - Ilker Selcuk
- a Department of Obstetrics and Gynaecology, Faculty of Medicine , Hacettepe University , Ankara , Turkey
| | - Lale K Sokmensuer
- b Department of Histology and Embryology, Faculty of Medicine , Hacettepe University , Ankara , Turkey
| | - Gurkan Bozdag
- a Department of Obstetrics and Gynaecology, Faculty of Medicine , Hacettepe University , Ankara , Turkey.,c Division of Reproductive Medicine and Infertility, Faculty of Medicine , Hacettepe University , Ankara , Turkey
| | - Roelof Menkveld
- d Department of Obstetrics and Gynaecology , Tygerberg Academic Hospital, Tygerberg , South Africa
| | - Serdar Gunalp
- a Department of Obstetrics and Gynaecology, Faculty of Medicine , Hacettepe University , Ankara , Turkey.,c Division of Reproductive Medicine and Infertility, Faculty of Medicine , Hacettepe University , Ankara , Turkey
| |
Collapse
|
19
|
Usubutun A, Selcuk I, Boyraz G, Tuncer ZS. An incidentally diagnosed epithelioid trophoblastic tumor in hysterectomy. Pathologica 2015; 107:201-204. [PMID: 26946877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023] Open
Abstract
Epithelioid trophoblastic tumor is a rare non-molar gestational trophoblastic disease. A 40-year-old multiparous woman was incidentally diagnosed with epithelioid trophoblastic tumor after hysterectomy. Hysterectomy specimen revealed multiple small, tan to yellow nodules measuring 0.3-0.8 cm just below the endometrium. In the microscopic examination uniform neoplastic cells with varying cellularity were accompanied by necrotic zones and eosinophilic hyaline material. Immunohistochemically neoplastic cells were diffusely stained with CK 7, inhibin-alpha, p63, hPL, and CD146. There was no staining with beta-HCG, SMA, PLAP, or h-caldesmon. Ki-67 proliferative index was approximately 10% and cyclin E was stained in approximately 10% of the neoplastic cells. Although immunohistochemical studies are helpful in classifying gestational trophoblastic lesions, borderline values can cause diagnostic confusion between neoplastic and reactive lesions, particularly in inadequate endometrial biopsies.
Collapse
|
20
|
Gungorduk K, Ozdemir A, Ertas IE, Selcuk I, Solmaz U, Ozgu E, Mat E, Gokcu M, Karadeniz T, Akbay S, Sanci M, Meydanli MM, Ayaz D, Gungor T. Is mucinous adenocarcinoma of the endometrium a risk factor for lymph node involvement? A multicenter case-control study. Int J Clin Oncol 2014; 20:782-9. [PMID: 25380693 DOI: 10.1007/s10147-014-0767-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2014] [Accepted: 10/21/2014] [Indexed: 11/26/2022]
Abstract
PURPOSE The purpose of this multicenter case-control study was to compare the demographic and clinical characteristics of patients with mucinous adenocarcinoma of the endometrium (MAE) and endometrioid endometrial carcinoma (EEC). METHODS A retrospective review of two cancer registry databases in Turkey was conducted to identify patients diagnosed with MAE between January 1996 and December 2012. Each patient was matched with a control EEC patient by age and tumor grade. Cases and controls were compared in terms of known risk factors for lymph node metastasis, disease-free survival (DFS), and overall survival (OS). RESULTS The analysis included 112 patients with MAE and 112 with EEC. No significant difference in baseline characteristics was evident between the two groups. Lymphovascular space invasion, deep myometrial invasion, cervical involvement, and tumor diameter did not differ significantly between the mucinous and endometrioid cases. Multivariate analysis confirmed that only mucinous histology (OR 2.2, 95 % CI 1.1-4.5; P = 0.02) was an independent predictor of lymph node involvement. Although the median DFS and OS tended to be better in the endometrioid group, the differences were not statistically significant. Routine appendectomy was performed in 52 (46.2 %) patients with MAE. No mucinous tumor of the appendix was identified. CONCLUSION Routine appendectomy is not necessary when the appendix is grossly normal at the time of surgery for MAE. Although the DFS and OS of EEC and MAE patients were similar, the risk of nodal metastasis in MAE patients was greater than that in ECC patients, and we thus suggest to perform retroperitoneal lymphadenectomy (both pelvic and para-aortic) for patients with MAE during the initial operation.
Collapse
Affiliation(s)
- Kemal Gungorduk
- Department of Gynecologic Oncology, Tepecik Education and Research Hospital, Gaziler Street, 35120, Izmir, Turkey,
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Basaran D, Salman MC, Boyraz G, Selcuk I, Usubutun A, Ozgul N, Yuce K. Accuracy of intraoperative frozen section in the evaluation of patients with adnexal mass: retrospective analysis of 748 cases with multivariate regression analysis. Pathol Oncol Res 2014; 21:113-8. [PMID: 24848925 DOI: 10.1007/s12253-014-9795-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2014] [Accepted: 05/06/2014] [Indexed: 11/30/2022]
Abstract
OBJECTIVE To evaluate the accuracy of intraoperative frozen section in the evaluation of patients with adnexal mass and to define the clinicopathological factors associated with misdiagnosis during frozen section evaluation. METHODS The clinicopathological data of patients who underwent exploratory laparotomy for adnexal mass were reviewed. Results of the intraoperative frozen section and permanent histology reports were compared. Univariate and multivariate analyses were performed to reveal factors associated with misdiagnosis. RESULTS The study group consisted of 748 patients. Of these patients, 509 (68.0%) had benign, 43 (5.7%) had borderline, 196 (26.2%) had malignant histological diagnosis at permanent section. The overall agreement between intraoperative frozen section and permanent pathology was 96.8%. Twenty four out of 745 cases (3.8%) were misdiagnosed by frozen section. Univariate analysis showed that borderline histology (p < 0.0001) and tumor size larger than 10 cm (p = 0.012) were associated with misdiagnosis. According to multivariate analysis, borderline histology (OR: 22.6, p < 0.0001) was the only independent predictor for misdiagnosis during frozen examination. CONCLUSION The frozen section evaluation of the adnexal mass is highly accurate. However, tumor size greater than 10 cm and borderline histology are the factors that adversely influence the accuracy of intraoperative frozen section. Clinicians must be aware of these pitfalls during intraoperative decision making following frozen section report.
Collapse
Affiliation(s)
- Derman Basaran
- Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Faculty of Medicine, Hacettepe University, 06100, Sihhiye, Ankara, Turkey
| | | | | | | | | | | | | |
Collapse
|
22
|
Turgal M, Selcuk I, Ozyuncu O. Pregnancy outcome of five patients with renal amyloidosis regarding familial Mediterranean fever. Ren Fail 2013; 36:306-8. [DOI: 10.3109/0886022x.2013.846863] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
23
|
Boyraz G, Selcuk I, Yazıcıoğlu A, Tuncer ZS. Ovarian carcinoma associated with endometriosis. Eur J Obstet Gynecol Reprod Biol 2013; 170:211-3. [DOI: 10.1016/j.ejogrb.2013.06.001] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2012] [Revised: 04/03/2013] [Accepted: 06/03/2013] [Indexed: 01/09/2023]
|
24
|
Tuncer ZS, Boyraz G, Selcuk I, Şahin N, Kaynaroğlu V, Özışık Y. Adnexal masses in women with breast cancer. Aust N Z J Obstet Gynaecol 2012; 52:266-9. [DOI: 10.1111/j.1479-828x.2012.01430.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2011] [Accepted: 02/23/2012] [Indexed: 11/28/2022]
Affiliation(s)
- Zafer Selcuk Tuncer
- Department of Obstetrics and Gynecology; Hacettepe University Faculty of Medicine; Ankara; Turkey
| | - Gokhan Boyraz
- Department of Obstetrics and Gynecology; Hacettepe University Faculty of Medicine; Ankara; Turkey
| | - Ilker Selcuk
- Department of Obstetrics and Gynecology; Hacettepe University Faculty of Medicine; Ankara; Turkey
| | - Nihal Şahin
- Department of Obstetrics and Gynecology; Hacettepe University Faculty of Medicine; Ankara; Turkey
| | - Volkan Kaynaroğlu
- Department of General Surgery; Hacettepe University Faculty of Medicine; Ankara; Turkey
| | - Yavuz Özışık
- Department of Medical Oncology; Hacettepe University Faculty of Medicine; Ankara; Turkey
| |
Collapse
|
25
|
Buyukasik Y, Boyraz G, Selcuk I, Bektas O, Selcuk Tuncer Z. Giant abdominopelvic haematoma arising from ovulation in a Glanzmann's thrombasthenia patient with platelet refractoriness: treatment with surgery and intra-abdominal tranexamic acid. Acta Haematol 2012; 128:154-7. [PMID: 22890234 DOI: 10.1159/000339085] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2011] [Accepted: 04/24/2012] [Indexed: 11/19/2022]
Abstract
Glanzmann's thrombasthenia (GT) is a very rare autosomal recessive genetic bleeding disorder. Women with coagulation abnormalities are at increased risk of corpus luteum rupture and haemoperitoneum. Here we present a severe case of GT resulting in a haematoma extending from the pelvis to the liver that could only be controlled by surgery and intra-abdominal tranexamic acid.
Collapse
Affiliation(s)
- Yahya Buyukasik
- Hematology Unit, Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey
| | | | | | | | | |
Collapse
|